Cargando…
Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience
BACKGROUND/AIM: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional immunosuppressive agents. The aim of this study is to assess the efficacy and safety...
Autores principales: | KILIÇ, Levent, KARADAĞ, Ömer, ERDEN, Abdulsamet, SARI, Alper, ARMAĞAN, Berkan, YARDIMCI, Gözde Kübra, FIRAT, Esra, KALYONCU, Umut, APRAŞ BİLGEN, Şule, KİRAZ, Sedat, ERTENLİ, İhsan, AKDOĞAN, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080363/ https://www.ncbi.nlm.nih.gov/pubmed/31655524 http://dx.doi.org/10.3906/sag-1906-39 |
Ejemplares similares
-
The impact of antiphospholipid antibodies in Takayasu arteritis
por: FIRAT ŞENTÜRK, Esra, et al.
Publicado: (2022) -
Imaging modalities used in diagnosis and follow-up of patients with Takayasu’s arteritis
por: KELEŞOĞLU DİNÇER, Ayşe Bahar, et al.
Publicado: (2021) -
Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results
por: Armagan, Berkan, et al.
Publicado: (2018) -
Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis
por: Kilic, Levent, et al.
Publicado: (2018) -
Capillaroscopic findings in Turkish Takayasu arteritis patients
por: AKDOĞAN, Ali, et al.
Publicado: (2019)